NTBL - Notable Labs Ltd
IEX Last Trade
0.562
-0.053 -9.413%
Share volume: 28,478
Last Updated: Fri 30 Aug 2024 05:08:06 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.61
-0.05
-8.60%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-5.22%
1 Month
-6.32%
3 Months
-44.16%
6 Months
-60.99%
1 Year
161.28%
2 Year
155.08%
Key data
Stock price
$0.56
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.15 - $5.27
52 WEEK CHANGE
$1.65
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Dror Harats
Region: US
Website: http://www.vblrx.com
Employees: 17
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.vblrx.com
Employees: 17
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
vascular biogenics ltd. is a biotechnology company located in 6yonatan netanyahu street, yehud, center district, israel.
Recent news